![Alan Hoberman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Hoberman
Director/Board Member at
BIOXYTRAN, INC.
Net worth: 15 029 $ as of 31/07/2026
Profile
Dr. Alan M.
Hoberman is an Independent Director at BioXyTran, Inc. and a President & Chief Executive Officer at Argus International, Inc. He is on the Board of Directors at BioXyTran, Inc. Dr. Hoberman was previously employed as an Independent Director by Boston Therapeutics, Inc., an Executive Director-Site Operations & Toxicology by Argus Research Laboratories, Inc., and an Independent Director by Oxygen Therapy, Inc. He also served on the board at BioXyTran, Inc. /Old/.
He received his undergraduate degree from Drexel University, a graduate degree from The University of Arkansas and a doctorate degree from Pacific Western University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOXYTRAN, INC. 0.96% | 14/11/2025 | 416,207 ( 0.96% ) | 9 989 $ | 31/07/2026 |
BIOXYTRAN, INC. 0.21% | 18/11/2025 | 210,000 ( 0.21% ) | 5 040 $ | 31/07/2026 |
Alan Hoberman active positions
| Companies | Position | Start |
|---|---|---|
| BIOXYTRAN, INC. | Director/Board Member | 02/11/2018 |
Argus International, Inc.
 Argus International, Inc. Industrial MachineryProducer Manufacturing Manufactures and sells printed circuit boards and thin film coating equipment | Chief Executive Officer | - |
Former positions of Alan Hoberman
| Companies | Position | End |
|---|---|---|
Oxygen Therapy, Inc.
 Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-necrosis drugs | Director/Board Member | 03/08/2018 |
| NANOMIX CORPORATION | Director/Board Member | 15/09/2016 |
Argus Research Laboratories, Inc. | Corporate Officer/Principal | 01/01/2013 |
BioXyTran, Inc. /Old/
 BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Board Member | - |
Training of Alan Hoberman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Arkansas
 The University of Arkansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacific Western University
 Pacific Western University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argus International, Inc.
Argus International, Inc. Industrial MachineryProducer Manufacturing Manufactures and sells printed circuit boards and thin film coating equipment | Producer Manufacturing |
Argus Research Laboratories, Inc. | |
Boston Therapeutics, Inc.
 Boston Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and commercializes pharmaceutical products | Health Technology |
Oxygen Therapy, Inc.
Oxygen Therapy, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-necrosis drugs | Health Technology |
BioXyTran, Inc. /Old/
BioXyTran, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
BioXyTran, Inc.
 BioXyTran, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that engages in the development, manufacture and commercialization of therapeutic drugs | Health Technology |
- Stock Market
- Insiders
- Alan Hoberman
